Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

HIV-1 Infection Accelerates Age According to the Epigenetic Clock

Open access
Horvath, Steve, Levine, Andrew J. · 2015 · Journal of Infectious Diseases

Abstract

BACKGROUND: Infection with human immunodeficiency virus type 1 (HIV) is associated with clinical symptoms of accelerated aging, as evidenced by the increased incidence and diversity of age-related illnesses at relatively young ages and supporting findings of organ and cellular pathologic analyses. But it has been difficult to detect an accelerated aging effect at a molecular level. METHODS: Here, we used an epigenetic biomarker of aging based on host DNA methylation levels to study accelerated aging effects due to HIV infection. DNA from brain and blood tissue was assayed via the Illumina Infinium Methylation 450 K platform. RESULTS: Using 6 novel DNA methylation data sets, we show that HIV infection leads to an increase in epigenetic age both in brain tissue (7.4 years) and blood (5.2 years). While the observed accelerated aging effects in blood may reflect changes in blood cell composition (notably exhausted cytotoxic T cells), it is less clear what explains the observed accelerated aging effects in brain tissue. CONCLUSIONS: Overall, our results demonstrate that the epigenetic clock is a useful biomarker for detecting accelerated aging effects due to HIV infection. This tool can be used to accurately determine the extent of age acceleration in individual tissues and cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jiv277

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Discovery brain data from human immunodeficiency virus (HIV)–infected subjects (cases) and HIV-uninfected subjects (controls). A–D, DNA methylation (DNAm) age versus chronological age in all brain samples (A) and occipital cortex (B), cerebellum (C), and frontal lobe (D) samples. Red squares and black triangles in the scatterplot denote samples from cases and controls, respectively. The orange line depicts a linear regression line through case samples. Similarly, the black solid line corresponds to a regression line of DNAm age on chronological age in control samples. For each subject (point), age acceleration is defined as the vertical distance to the black regression line (ie, DNAm age minus the expected value based on control samples). E, Mean age acceleration versus control status in all brain samples. Each bar plot depicts 1 standard error around the mean value and reports the Kruskal–Wallis (nonparametric) group comparison test P value. Analogous results can be obtained when restricting the analysis to occipital cortex (B and F) or cerebellar (C and G) samples but not for samples from the frontal lobe (D and G). E–H, The group comparisons in panels E–H involved a total of 130, 72, 24, and 24, samples respectively. The number of samples in each group is reported by the rotated number under each bar. I–L, HIV load (log10 transformed) in cerebrospinal fluid (CSF) of cases versus age acceleration in all brain samples (I) and occipital cortex (J), cerebellum (K), and frontal lobe (L) samples. Abbreviation: cor, correlation.
Figure 1. Discovery brain data from human immunodeficiency virus (HIV)–infected subjects (cases) and HIV-uninfected subjects (controls). A–D, DNA methylation (DNAm) age versus chronological age in all brain samples (A) and occipital cortex (B), cerebellum (C), and frontal lobe (D) samples. Red squares and black triangles in the scatterplot denote samples from cases and controls, respectively. The orange line depicts a linear regression line through case samples. Similarly, the black solid line corresponds to a regression line of DNAm age on chronological age in control samples. For each subject (point), age acceleration is defined as the vertical distance to the black regression line (ie, DNAm age minus the expected value based on control samples). E, Mean age acceleration versus control status in all brain samples. Each bar plot depicts 1 standard error around the mean value and reports the Kruskal–Wallis (nonparametric) group comparison test P value. Analogous results can be obtained when restricting the analysis to occipital cortex (B and F) or cerebellar (C and G) samples but not for samples from the frontal lobe (D and G). E–H, The group comparisons in panels E–H involved a total of 130, 72, 24, and 24, samples respectively. The number of samples in each group is reported by the rotated number under each bar. I–L, HIV load (log10 transformed) in cerebrospinal fluid (CSF) of cases versus age acceleration in all brain samples (I) and occipital cortex (J), cerebellum (K), and frontal lobe (L) samples. Abbreviation: cor, correlation.CC BY-NC-ND · PubMed Central
Figure 2. Validation brain data from human immunodeficiency virus (HIV)–infected subjects (cases) and HIV-uninfected subjects (controls). Analogous to Figure 1, we used independent data sets (data 2 and 3) to relate HIV status to epigenetic age acceleration in the frontal lobe and cerebellum of cases and controls. A and B, DNA methylation (DNAm) age versus chronological age in cerebellum (A) and frontal lobe (B) samples. Points (subjects) are colored by HIV status: cases correspond to red squares. The orange and black lines depict regression lines case and control samples, respectively. The measure of age acceleration is the same as used in Figure 1. C and D, Age acceleration versus HIV status in cerebellum (C) and frontal lobe (D) specimens. Each bar plot reports the Kruskal–Wallis (nonparametric) group comparison test P value and 1 standard error around the mean. Abbreviation: cor, correlation.
Figure 2. Validation brain data from human immunodeficiency virus (HIV)–infected subjects (cases) and HIV-uninfected subjects (controls). Analogous to Figure 1, we used independent data sets (data 2 and 3) to relate HIV status to epigenetic age acceleration in the frontal lobe and cerebellum of cases and controls. A and B, DNA methylation (DNAm) age versus chronological age in cerebellum (A) and frontal lobe (B) samples. Points (subjects) are colored by HIV status: cases correspond to red squares. The orange and black lines depict regression lines case and control samples, respectively. The measure of age acceleration is the same as used in Figure 1. C and D, Age acceleration versus HIV status in cerebellum (C) and frontal lobe (D) specimens. Each bar plot reports the Kruskal–Wallis (nonparametric) group comparison test P value and 1 standard error around the mean. Abbreviation: cor, correlation.CC BY-NC-ND · PubMed Central
Figure 3. Epigenetic age in blood tissue versus human immunodeficiency virus (HIV) status. The first column (A and C) and second column (B and D) report findings for blood data sets 4 and 5, respectively. A and B, DNA methylation (DNAm) age versus chronological age. Samples from HIV-infected patients (cases; points) are colored in red. The black solid line and the orange line correspond to regression lines through HIV-uninfected control samples and case samples, respectively. For each subject (point), age acceleration is defined as the vertical distance to the black regression line. C and D, Mean age acceleration versus HIV status. The rotated numbers on the x-axis report the group sizes. The bar graphs report 1 standard error and a Kruskal–Wallis test P value. Abbreviation: cor, correlation.
Figure 3. Epigenetic age in blood tissue versus human immunodeficiency virus (HIV) status. The first column (A and C) and second column (B and D) report findings for blood data sets 4 and 5, respectively. A and B, DNA methylation (DNAm) age versus chronological age. Samples from HIV-infected patients (cases; points) are colored in red. The black solid line and the orange line correspond to regression lines through HIV-uninfected control samples and case samples, respectively. For each subject (point), age acceleration is defined as the vertical distance to the black regression line. C and D, Mean age acceleration versus HIV status. The rotated numbers on the x-axis report the group sizes. The bar graphs report 1 standard error and a Kruskal–Wallis test P value. Abbreviation: cor, correlation.CC BY-NC-ND · PubMed Central
Figure 4. Age acceleration versus blood cell counts in human immunodeficiency virus (HIV)–infected subjects (cases). Here we used DNA methylation (DNAm) data from peripheral blood mononuclear cells from cases (data set 6). A, DNAm age versus age. The red line indicates the regression line. The black line corresponds to y = x. Epigenetic age acceleration (defined as the residual) versus the percentage of natural killer (NK) cells (B), CD14+ monocytes (C), granulocytes (D), CD4+ T cells (E), CD8+ T cells (F), naive CD8+ T cells (G), and exhausted (CD28−CD45RA−) CD8+ T cells (H).
Figure 4. Age acceleration versus blood cell counts in human immunodeficiency virus (HIV)–infected subjects (cases). Here we used DNA methylation (DNAm) data from peripheral blood mononuclear cells from cases (data set 6). A, DNAm age versus age. The red line indicates the regression line. The black line corresponds to y = x. Epigenetic age acceleration (defined as the residual) versus the percentage of natural killer (NK) cells (B), CD14+ monocytes (C), granulocytes (D), CD4+ T cells (E), CD8+ T cells (F), naive CD8+ T cells (G), and exhausted (CD28−CD45RA−) CD8+ T cells (H).CC BY-NC-ND · PubMed Central
Figure 5. Age acceleration versus blood cell counts in HIV-uninfected control subjects (controls). The first 2 rows (A–H) and the last 2 rows (I–P) present results for controls from blood data sets 5 and 7, respectively. A and I, DNA methylation (DNAm) age versus chronological age. Age acceleration was defined as the residual resulting from the regression line (red line). Age acceleration versus natural killer (NK) cells (B and J), CD14+ monocytes (C and K), granulocytes (D and L), CD4+ T cells (E and M), CD8+ T cells (F and N), naive CD8+ T cells (G and O), and exhausted (CD28−CD45RA−) CD8+ T cells (H and P). The blood cell abundance measures were estimated on the basis of DNAm data (“Methods” section).
Figure 5. Age acceleration versus blood cell counts in HIV-uninfected control subjects (controls). The first 2 rows (A–H) and the last 2 rows (I–P) present results for controls from blood data sets 5 and 7, respectively. A and I, DNA methylation (DNAm) age versus chronological age. Age acceleration was defined as the residual resulting from the regression line (red line). Age acceleration versus natural killer (NK) cells (B and J), CD14+ monocytes (C and K), granulocytes (D and L), CD4+ T cells (E and M), CD8+ T cells (F and N), naive CD8+ T cells (G and O), and exhausted (CD28−CD45RA−) CD8+ T cells (H and P). The blood cell abundance measures were estimated on the basis of DNAm data (“Methods” section).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 100 references

Research works printed but not linked: 1

  1. Heaton, 1994, The utility of clinical ratings for detecting cognitive change in HIV infection

Cited by

See all 610

Metadata

Authors
Horvath, S., & Levine, A. J.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Horvath, Steve
Venue
Journal of Infectious Diseases
Published
2015-05-12
Volume
212
Issue
10
Pages
1563-1573
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2163887613
Cited by
556
References
100
Citations by year
2026: 35 · 2025: 33 · 2024: 66 · 2023: 51 · 2022: 66 · 2021: 59 · 2020: 50 · 2019: 43 · 2018: 54 · 2017: 51 · 2016: 36 · 2015: 11
FWCI
25.62
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • The Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging
  • National Institutes of Health
  • NIH (5R01AG042511-02, R01DA030913, U01-AI-35040)
  • the University of California, Los Angeles (UCLA) AIDS Institute
  • UCLA Center for AIDS Research (AI28697)
  • the UCLA Clinical and Translational Science Institute
  • National Center for Advancing Translational Sciences (UL1TR000124)
  • the National Institute for Drug Abuse
  • the National Institute of Allergy and Infectious Diseases
  • the Los Angeles site of the Multicenter AIDS Cohort Study [
  • the National NeuroAIDS Tissue Consortium
  • National Neurological AIDS Bank (U01-MH08021 and R24-NS38841;)
  • Texas NeuroAIDS Research Center (U01-MH083507 and R24-NS45491;)
  • Manhattan HIV Brain Bank (U01-MH083501 and R24-MH59724)
  • California NeuroAIDS Tissue Network (U01-MH083506 and R24-MH59745)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Keywords
HIV-1 infection, accelerated aging, epigenetic clocks, DNA methylation, epigenetic age, brain tissue, blood, aging biomarkers
MeSH terms
Adolescent, Adult, Aged, Aging, Blood Cells, Brain, DNA, Humans, Male, Methylation, Middle Aged, HIV-1, HIV Infections, Epigenesis, Genetic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV-1 Infection Accelerates Age According to the Epigenetic Clock. https://app.cochat.ai/papers/10.1093/infdis/jiv277
The paper
Horvath, S., & Levine, A. J. (2015). HIV-1 Infection Accelerates Age According to the Epigenetic Clock. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiv277

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.